ACIM
ABMD

Azimuth Capital Investment Management’s Abiomed Inc ABMD Stock Holding History

Azimuth Capital Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,586
Closed -$7.27M – 314
2022
Q3 		$7.27M Buy
29,586
+12
+0% +$3.24K 0.4% 79
2022
Q2 		$7.32M Buy
+29,574
New +$7.98M 0.37% 99

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Azimuth Capital Investment Management's ABMD Position: Q4 2022 in Review

Azimuth Capital Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 29,586 shares — an estimated $7.27M sold.

Azimuth Capital Investment Management first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $7.32M in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Azimuth Capital Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Azimuth Capital Investment Management sold 29,586 Abiomed Inc shares in Q4 2022, an estimated $7.27M.
  • Azimuth Capital Investment Management first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
  • Azimuth Capital Investment Management's Abiomed Inc position peaked at $7.32M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Azimuth Capital Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.